Evidence map›Paper›PMID 38825984›Full record

ArticleHuman vaccines & immunotherapeutics2024

SARS-CoV-2 and influenza vaccine hesitancy during the COVID-19 pandemic in a dynamic perspective.

Valentina Gerussi, Maddalena Peghin, Alvisa Palese, Maria De Martino, Elena Graziano, Stefania Chiappinotto, Federico Fonda, Giulia Bontempo, Tosca Semenzin, Luca Martini and 2 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Valentina GerussiInfectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy.ORCID 0000-0003-4527-2758
Maddalena PeghinInfectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy.ORCID 0000-0002-4640-679X
Alvisa PaleseDepartment of Medicine, School of Nursing, University of Udine, Udine, Italy.ORCID 0000-0002-3508-844X
Maria De MartinoDepartment of Medicine, Institute of Statistics, University of Udine, Udine, Italy.ORCID 0000-0002-0445-9578
Elena GrazianoInfectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy.ORCID 0000-0002-1157-9359
Stefania ChiappinottoDepartment of Medicine, School of Nursing, University of Udine, Udine, Italy.ORCID 0000-0003-4829-1831
Federico FondaDepartment of Medicine, School of Nursing, University of Udine, Udine, Italy.ORCID 0000-0002-3818-9676
Giulia BontempoInfectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy.
Tosca SemenzinInfectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy.
Luca MartiniInfectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy.
Miriam IsolaDepartment of Medicine, Institute of Statistics, University of Udine, Udine, Italy.ORCID 0000-0002-6391-1720
Carlo TasciniInfectious Diseases Division, Santa Maria Misericordia University Hospital, Udine, Italy.ORCID 0000-0001-9625-6024

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the dynamic evolution of vaccine hesitancy toward both COVID-19 and influenza in a context characterized by the compresence of SARS-CoV-2 pandemic and seasonal flu epidemics, a two times repeated cross-sectional exploratory design was performed at Udine Hospital (Italy) following a cohort of 479 adult patients with a previous history of SARS-CoV-2 infection in 2020. Vaccine attitude was assessed through standardized telephone interviews performed at 12 and 18 months after the acute illness. The first interview reported the success of the 2020/21 seasonal influenza immunization with 46.8% (224/479) of the participants showing a positive attitude, especially the elderly and people with comorbidities (

Indexed as

COVID-19COVID-19 VaccinesInfluenza, HumanInfluenza VaccinesVaccination HesitancyAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansItalyMaleMiddle AgedPandemicsCOVID-19 VaccinesInfluenza VaccinesCOVID-19Green-PassInfluenzaSARS-CoV-2vaccinationvaccine-hesitancy

Identifiers

PMID38825984
PMCPMC11152090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.